Tuesday, September 13, 2022 6:11:44 PM
Recent ADTX News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/29/2024 08:33:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 10:08:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:24:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
- Evofem Biosciences Announces Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/15/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:44 PM
- CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 06:14:00 PM
- Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 01:00:00 PM
- Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) • Business Wire • 04/02/2024 12:30:00 PM
- Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 • PR Newswire (US) • 03/27/2024 12:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:51:37 PM
- For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy • PR Newswire (US) • 03/07/2024 12:54:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/04/2024 10:27:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:24:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:01:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/22/2024 10:21:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:52 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:31:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:30:11 PM
FEATURED Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM